To request further information on the ASTRAL trial please use the details below.
Mrs Elizabeth Brettell, Team Leader
+44 (0)121 415 9130
Main BCTU switchboard: +44 (0)121 415 9100
Fax: +44 (0)121 415 9135
Email: renal-trials@contacts.bham.ac.uk
Useful links
Kidney Research UK
British Society of Interventional Radiology
Find out more information about our other renal trials and the University of Birmingham Clinical Trials Unit below:
BCTU
The University of Birmingham Clinical Trials Unit (BCTU) is a Research Unit within the School of Medicine specialising in the design, conduct and analysis of clinical trials.
PEXIVAS
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: an international randomised controlled trial.
PREDNOS
PREDNOS is a national multi centre randomised double blind trial of long-term tapering versus standard prednisolone (steroid) therapy for the treatment of the initial episode of childhood nephrotic syndrome.
PREDNOS 2
PREDNOS 2 is a phase III randomised parallel group, placebo-controlled, double-blind trial of short course daily prednisolone therapy at the time of upper respiratory tract infection in children with relapsing steroid sensitive nephrotic syndrome.
STOP-ACEi
STOP-ACEi is a multi-centre, randomised controlled trial of Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) withdrawal in advanced kidney disease.